Will "cerebral proteopathy" be a useful construct for discovering one drug that shows efficacy against multiple neurodegenerative diseases?
Gandy
S
S
New York University Medical Center Department of Psychiatry, and Nathan Kline Institute, Orangeburg, NY 10962, USA. gandy@nki.rfmh.org
D001923:Brain Chemistry; D004358:Drug Therapy / Q000639:trends*; D006801:Humans; D019636:Neurodegenerative Diseases / Q000188:drug therapy*; D009462:Neurology / Q000639:trends*; D009626:Terminology as Topic